Neuropathology of white matter lesions, blood-brain barrier dysfunction, and dementia

Stroke

Volumn 48, Issue 10, 2017, Pages 2799-2804

  Hainsworth, Atticus H ^a,b   Minett, Thais ^c   Andoh, Joycelyn ^a   Forster, Gillian ^d   Bhide, Ishaan ^a   Barrick, Thomas R ^a   Elderfield, Kay ^b   Jeevahan, Jamuna ^b   Markus, Hugh S ^c   Bridges, Leslie R ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Dementia; Fibrinogen; Leukoaraiosis; Neuropathology; Vascular cognitive impairment; White matter

Indexed keywords

CD68 ANTIGEN; FIBRINOGEN; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

AGED; ARTICLE; AXON; BLOOD BRAIN BARRIER; CELL LABELING; CONTROLLED STUDY; DEMENTIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROGLIA; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PRIORITY JOURNAL; VERY ELDERLY; WHITE MATTER LESION; LONGITUDINAL STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; WHITE MATTER;

AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; DEMENTIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; WHITE MATTER;

EID: 85031089034     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.117.018101     Document Type: Article

References (34)

1. Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11:157-165. doi: 10.1038/nrneurol.2015.10.
2. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34:806-812. doi: 10.1161/01. STR.0000058480.77236. B3.
3. Erickson MA, Banks WA. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab. 2013;33:1500-1513. doi: 10.1038/jcbfm.2013.135.
4. Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Muñoz Maniega S, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol. 2009;65:194-202. doi: 10.1002/ana.21549.
5. Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, et al. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke. 2011;42:2158-2163. doi: 10.1161/STROKEAHA.110.611731.
6. Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry. 2010;81:192-197. doi: 10.1136/jnnp. 2009.172072.
7. Huisa BN, Caprihan A, Thompson J, Prestopnik J, Qualls CR, Rosenberg GA. Long-term blood-brain barrier permeability changes in Binswanger disease. Stroke. 2015;46:2413-2418. doi: 10.1161/STROKEAHA.115.009589.
8. Zhang CE, Wong SM, van de Haar HJ, Staals J, Jansen JF, Jeukens CR, et al. Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease. Neurology. 2017;88:426-432. doi: 10.1212/WNL.0000000000003556.
9. Simpson JE, Wharton SB, Cooper J, Gelsthorpe C, Baxter L, Forster G, et al. Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain. Neurosci Lett. 2010;486:246-251. doi: 10.1016/j.neulet.2010.09.063.
10. Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H, Nakamura S, et al. Alterations of the blood-brain barrier and glial cells in whitematter lesions in cerebrovascular and Alzheimer's disease patients. Stroke. 1996;27:2069-2074.
11. Bridges LR, Andoh J, Lawrence AJ, Khoong C H L, Poon W, Esiri MM, et al. Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people. J Neuropathol Exp Neurol. 2014;73:1026-1033. doi: 10.1097/NEN.0000000000000124.
12. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology. 2008;71:804-811. doi: 10.1212/01. wnl.0000319691.50117.54.
13. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C; Medical Research Council Cognitive Function and Ageing Study. Age, neuropathology, and dementia. N Engl J Med. 2009;360:2302-2309. doi: 10.1056/NEJMoa0806142.
14. Richardson K, Stephan BC, Ince PG, Brayne C, Matthews FE, Esiri MM. The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Curr Alzheimer Res. 2012;9:687-696.
15. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, et al; MRC Cognitive Function and Ageing Neuropathology Study Group. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391-1398. doi: 10.1161/01. STR.0000221308.94473.14.
16. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med. 2009;6:e1000180. doi: 10.1371/journal.pmed.1000180.
17. Fernando MS, O'Brien JT, Perry RH, English P, Forster G, McMeekin W, et al; Neuropathology Group of MRC CFAS. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol. 2004;30:385-395. doi: 10.1111/j.1365-2990.2004.00550.x.
18. Utter S, Tamboli I Y, Walter J, Upadhaya AR, Birkenmeier G, Pietrzik CU, et al. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. J Neuropathol Exp Neurol. 2008;67:842-856. doi: 10.1097/NEN.0b013e3181836a71.
19. Hultman K, Strickland S, Norris EH. The APOE ϵ4/ϵ4 genotype potentiates vascular fibrin (ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients. J Cereb Blood Flow Metab. 2013;33:1251-1258. doi: 10.1038/jcbfm.2013.76.
20. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296-302. doi: 10.1016/j.neuron. 2014.12.032.
21. Halliday MR, Pomara N, Sagare AP, Mack WJ, Frangione B, Zlokovic BV. Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown. JAMA Neurol. 2013;70:1198-1200. doi: 10.1001/jamaneurol.2013.3841.
22. Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 2016;537:50-56. doi: 10.1038/nature19323.
23. Morita T, Mizutani Y, Sawada M, Shimada A. Immunohistochemical and ultrastructural findings related to the blood-brain barrier in the blood vessels of the cerebral white matter in aged dogs. J Comp Pathol. 2005;133:14-22. doi: 10.1016/j.jcpa.2005.01.001.
24. Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11:457-470. doi: 10.1038/nrneurol.2015.119.
25. Bien-Ly N, Boswell CA, Jeet S, Beach TG, Hoyte K, Luk W, et al. Lack of widespread BBB disruption in Alzheimer's disease models: focus on therapeutic antibodies. Neuron. 2015;88:289-297. doi: 10.1016/j. neuron. 2015.09.036.
26. Faraco G, Sugiyama Y, Lane D, Garcia-Bonilla L, Chang H, Santisteban MM, et al. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J Clin Invest. 2016;126:4674-4689. doi: 10.1172/JCI86950.
27. Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 2014;509:507-511. doi: 10.1038/nature13324.
28. Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, et al. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging. 2007;28:977-986. doi: 10.1016/j. neurobiolaging.2006.05.016.
29. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic B V. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol. 2013;23:303-310. doi: 10.1111/bpa.12004.
30. Paul J, Strickland S, Melchor J P. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med. 2007;204:1999-2008. doi: 10.1084/jem.20070304.
31. Davalos D, Ryu JK, Merlini M, Baeten KM, Le Moan N, Petersen MA, et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun. 2012;3:1227. doi: 10.1038/ncomms2230.
32. van Horssen J, Singh S, van der Pol S, Kipp M, Lim JL, Peferoen L, et al. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation. 2012;9:156. doi: 10.1186/1742-2094-9-156.
33. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Sizeselective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161:653-660. doi: 10.1083/jcb.200302070.
34. Dawe RJ, Bennett DA, Schneider JA, Leurgans SE, Kotrotsou A, Boyle PA, et al. Ex vivo T2 relaxation: associations with age-related neuropathology and cognition. Neurobiol Aging. 2014;35:1549-1561. doi: 10.1016/j.neurobiolaging.2014.01.144.